The guidelines do not recommend albumin as first-line therapy for indications such as nutritional intervention, hyperbilirubinemia, cirrhosis and paracentesis, and nephrotic syndrome. The ...

Caution is urged with early albumin use in septic shock and kidney impairment, especially with hyperoncotic vs isooncotic ...

Sequana Medical NV received premarket approval from the U.S. FDA for its Alfapump system to treat recurrent or refractory ascites due to liver cirrhosis. Data from the Poseidon pivotal study showed ...